GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,074,000 | -29.9% | 25,051 | -50.0% | 0.12% | -40.9% |
| Q1 2020 | $4,387,000 | -16.3% | 50,101 | 0.0% | 0.20% | 0.0% |
| Q4 2019 | $5,239,000 | -29.4% | 50,101 | -22.3% | 0.20% | -38.9% |
| Q3 2019 | $7,419,000 | -33.3% | 64,499 | 0.0% | 0.32% | -28.6% |
| Q2 2019 | $11,119,000 | +89.0% | 64,499 | +84.9% | 0.45% | +90.0% |
| Q1 2019 | $5,882,000 | -4.7% | 34,891 | -44.9% | 0.24% | -9.5% |
| Q4 2018 | $6,169,000 | -18.1% | 63,345 | +45.3% | 0.26% | -3.3% |
| Q3 2018 | $7,531,000 | -24.5% | 43,598 | -39.0% | 0.27% | -28.0% |
| Q2 2018 | $9,977,000 | -20.1% | 71,497 | -35.5% | 0.38% | -21.9% |
| Q1 2018 | $12,482,000 | +278.2% | 110,784 | +343.1% | 0.48% | +281.9% |
| Q4 2017 | $3,300,000 | +58.4% | 25,000 | -16.7% | 0.13% | +67.1% |
| Q4 2015 | $2,083,000 | -83.2% | 30,000 | -77.8% | 0.08% | -82.9% |
| Q3 2015 | $12,372,000 | – | 135,400 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
| VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
| Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
| United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
| PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
| Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
| CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
| Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |